(Q52959602)

9 May 2018

title

Circulating Soluble Fas and Fas Ligand Levels Are Elevated in Children with Nonalcoholic Steatohepatitis. (English)

1 reference

9 May 2018

0 references

2

1 reference

9 May 2018

Annalisa Crudele

Annalisa Crudele

6

0 references

Federica Ferrari

Federica Ferrari

5

0 references

Valerio Nobili

Valerio Nobili

10

0 references

Ariel E Feldstein

9

Ariel E Feldstein

1 reference

9 May 2018

Rita De Vito

7

Rita De Vito

1 reference

9 May 2018

Naim Alkhouri

1

Naim Alkhouri

1 reference

9 May 2018

author name string

Vera Okwu

3

1 reference

9 May 2018

Ammar Matloob

4

1 reference

9 May 2018

Rocio Lopez

8

1 reference

9 May 2018

publication date

13 March 2015

1 reference

9 May 2018

Digestive Diseases and Sciences

published in

1 reference

9 May 2018

volume

60

1 reference

9 May 2018

issue

8

1 reference

9 May 2018

page(s)

2353-2359

1 reference

9 May 2018

https://scigraph.springernature.com/pub.10.1007/s10620-015-3614-z

exact match

0 references

cites work

The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3614-Z

Pathology of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3614-Z

Nonalcoholic fatty liver disease in children: recent practice guidelines, where do they take us?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3614-Z

Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3614-Z

Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3614-Z

Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3614-Z

An apoptosis panel for nonalcoholic steatohepatitis diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3614-Z

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3614-Z

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3614-Z

A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin-18 for the diagnosis of non-alcoholic steatohepatitis in morbidly obese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3614-Z

Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3614-Z

The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3614-Z

Noninvasive assessment of liver disease severity with liver fat score and CK-18 in NAFLD: Prognostic value of liver fat equation goes beyond hepatic fat estimation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3614-Z

Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3614-Z

A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3614-Z

Serum cytokeratin-18 fragment levels are useful biomarkers for nonalcoholic steatohepatitis in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3614-Z

Redox mechanisms in hepatic chronic wound healing and fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3614-Z

Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3614-Z

Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3614-Z

Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3614-Z

A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosis

21 January 2018

1 reference

12 December 2020

Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis

1 reference

12 December 2020

Serum levels of CK18 M30 and leptin are useful predictors of steatohepatitis and fibrosis in paediatric NAFLD

1 reference

12 December 2020

In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease

1 reference

12 December 2020

10.1007/S10620-015-3614-Z

Identifiers

DOI

1 reference

9 May 2018

1 reference

9 May 2018